BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 9576810)

  • 1. A series of 6-(omega-methanesulfonylthioalkoxy)-2-N-methyl- 1,2,3, 4-tetrahydroisoquinolines: cysteine-reactive molecular yardsticks for probing alpha2-adrenergic receptors.
    Heinonen P; Koskua K; Pihlavisto M; Marjamäki A; Cockcroft V; Savola JM; Scheinin M; Lönnberg H
    Bioconjug Chem; 1998; 9(3):358-64. PubMed ID: 9576810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced stability of wild-type and constitutively active alpha(2A)-adrenoceptors by ligands with agonist, silent and inverse agonist properties.
    Pauwels PJ; Tardif S
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):134-41. PubMed ID: 12122500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ethyl-3H]RS-79948-197 alpha2-adrenoceptor autoradiography validation in alpha2-adrenoceptor knockout mice.
    Fagerholm V; Philipp M; Hein L; Scheinin M
    Eur J Pharmacol; 2004 Aug; 497(3):301-9. PubMed ID: 15336948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor antibiotic fostriecin covalently binds to cysteine-269 residue of protein phosphatase 2A catalytic subunit in mammalian cells.
    Takeuchi T; Takahashi N; Ishi K; Kusayanagi T; Kuramochi K; Sugawara F
    Bioorg Med Chem; 2009 Dec; 17(23):8113-22. PubMed ID: 19857968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of reversible cysteine-targeted protein oxidation by an endogenous electrophile 15-deoxy-delta12,14-prostaglandin J2.
    Ishii T; Uchida K
    Chem Res Toxicol; 2004 Oct; 17(10):1313-22. PubMed ID: 15487891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, biochemical evaluation, and classical and three-dimensional quantitative structure-activity relationship studies of 7-substituted-1,2,3,4-tetrahydroisoquinolines and their relative affinities toward phenylethanolamine N-methyltransferase and the alpha2-adrenoceptor.
    Grunewald GL; Dahanukar VH; Jalluri RK; Criscione KR
    J Med Chem; 1999 Jan; 42(1):118-34. PubMed ID: 9888838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass spectrometric investigation of the mechanism of inactivation of hamster arylamine N-acetyltransferase 1 by N-hydroxy-2-acetylaminofluorene.
    Guo Z; Wagner CR; Hanna PE
    Chem Res Toxicol; 2004 Mar; 17(3):275-86. PubMed ID: 15025497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical role of the N-methyl-D-aspartate (NMDA) receptor subunit (NR) 2A in the expression of redox sensitivity of NR1/NR2A recombinant NMDA receptors.
    Brimecombe JC; Potthoff WK; Aizenman E
    J Pharmacol Exp Ther; 1999 Nov; 291(2):785-92. PubMed ID: 10525101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selected cysteine residues in transmembrane domains of mu-opioid receptor are critical for effects of sulfhydryl reagents.
    Deng HB; Guang W; Wang JB
    J Pharmacol Exp Ther; 2000 Apr; 293(1):113-20. PubMed ID: 10734160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fipamezole (JP-1730) is a potent alpha2 adrenergic receptor antagonist that reduces levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease.
    Savola JM; Hill M; Engstrom M; Merivuori H; Wurster S; McGuire SG; Fox SH; Crossman AR; Brotchie JM
    Mov Disord; 2003 Aug; 18(8):872-83. PubMed ID: 12889076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of [(3)H]idazoxan binding sites on human platelets.
    Ruiz J; Barinagarrementeria G; Martín-Gómez JI; Callado LF; Meana JJ
    Platelets; 2002 Jun; 13(4):241-6. PubMed ID: 12189026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3,7-Disubstituted-1,2,3,4-tetrahydroisoquinolines display remarkable potency and selectivity as inhibitors of phenylethanolamine N-methyltransferase versus the alpha2-adrenoceptor.
    Grunewald GL; Dahanukar VH; Teoh B; Criscione KR
    J Med Chem; 1999 Jun; 42(11):1982-90. PubMed ID: 10354406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiparkinsonian agent piribedil displays antagonist properties at native, rat, and cloned, human alpha(2)-adrenoceptors: cellular and functional characterization.
    Millan MJ; Cussac D; Milligan G; Carr C; Audinot V; Gobert A; Lejeune F; Rivet JM; Brocco M; Duqueyroix D; Nicolas JP; Boutin JA; Newman-Tancredi A
    J Pharmacol Exp Ther; 2001 Jun; 297(3):876-87. PubMed ID: 11356907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular modelling of subtypes (alpha(2A), alpha(2B) and alpha(2C)) of alpha(2)-adrenoceptors: a comparative study.
    Balogh B; Szilágyi A; Gyires K; Bylund DB; Mátyus P
    Neurochem Int; 2009 Nov; 55(6):355-61. PubMed ID: 19447153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequencing of a branched peptide using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Fournier I; Chaurand P; Bolbach G; Lützenkirchen F; Spengler B; Tabet JC
    J Mass Spectrom; 2000 Dec; 35(12):1425-33. PubMed ID: 11180633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
    Frändberg PA; Doufexis M; Kapas S; Chhajlani V
    Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenoxybenzamine and benextramine, but not 4-diphenylacetoxy-N-[2-chloroethyl]piperidine hydrochloride, display irreversible noncompetitive antagonism at G protein-coupled receptors.
    Bodenstein J; Venter DP; Brink CB
    J Pharmacol Exp Ther; 2005 Aug; 314(2):891-905. PubMed ID: 15857948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective detection of peptides containing cysteine sulfonic acid using matrix-assisted laser desorption/ionization and laser desorption/ionization on porous silicon mass spectrometry.
    Kinumi T; Shimomae Y; Arakawa R; Tatsu Y; Shigeri Y; Yumoto N; Niki E
    J Mass Spectrom; 2006 Jan; 41(1):103-12. PubMed ID: 16382481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes.
    Millan MJ; Maiofiss L; Cussac D; Audinot V; Boutin JA; Newman-Tancredi A
    J Pharmacol Exp Ther; 2002 Nov; 303(2):791-804. PubMed ID: 12388666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. alpha(2A)-adrenergic receptor derived peptide adsorbates: a G-protein interaction study.
    Vahlberg C; Petoral RM; Lindell C; Broo K; Uvdal K
    Langmuir; 2006 Aug; 22(17):7260-4. PubMed ID: 16893224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.